Cargando…

As predicted by hyperfunction theory, rapamycin treatment during development extends lifespan

Detalles Bibliográficos
Autor principal:	Blagosklonny, Mikhail V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954961/ https://www.ncbi.nlm.nih.gov/pubmed/35306486 http://dx.doi.org/10.18632/aging.203937

Ejemplares similares

Cell senescence, rapamycin and hyperfunction theory of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
por: Blagosklonny, Mikhail V.
Publicado: (2022)

The hyperfunction theory of aging: three common misconceptions
por: Blagosklonny, Mikhail V.
Publicado: (2021)

Rapamycin for the aging skin
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
por: Komarova, Elena A., et al.
Publicado: (2012)

DNA- and telomere-damage does not limit lifespan: evidence from rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2021)

New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53(−/−) mice by delaying carcinogenesis
por: Comas, Maria, et al.
Publicado: (2012)

Rapamycin extends life- and health span because it slows aging
por: Blagosklonny, Mikhail V.
Publicado: (2013)

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Applied hyperfunction theory
por: Imai, Isao
Publicado: (1992)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Rapamycin for longevity: opinion article
por: Blagosklonny, Mikhail V.
Publicado: (2019)

The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
por: Li, Shulin
Publicado: (2009)

Does rapamycin slow down time?
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Operational calculus: a theory of hyperfunctions
por: Yosida, K
Publicado: (1984)

Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster
por: Aiello, Giuseppe, et al.
Publicado: (2022)

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

The hyperfunction theory: an emerging paradigm for the biology of aging
por: Gems, David
Publicado: (2022)

Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
por: Harrison, David E., et al.
Publicado: (2009)

Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Target of rapamycin activation predicts lifespan in fruit flies
por: Scialò, Filippo, et al.
Publicado: (2015)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Botulinum toxin for the treatment of hyperfunctional lines of the forehead
por: Sunil, Sathigrama Malegowda, et al.
Publicado: (2015)

No limit to maximal lifespan in humans: how to beat a 122-year-old record
por: Blagosklonny, Mikhail V.
Publicado: (2021)

An introduction to Sato's hyperfunctions
por: Morimoto, Mitsuo
Publicado: (1993)

Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2013)

Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis
por: Blagosklonny, Mikhail V.
Publicado: (2010)

While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017)

Rapamycin prolongs female reproductive lifespan
por: Luo, Li-li, et al.
Publicado: (2013)

Long‐term treatment of cancer‐prone germline PTEN mutant mice with low‐dose rapamycin extends lifespan and delays tumour development
por: Tibarewal, Priyanka, et al.
Publicado: (2022)

Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
por: Siegmund, Stephanie E, et al.
Publicado: (2017)

Correction for: Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2020)

Dietary restriction and other lifespan extending pathways converge at the activation of the downstream effector takeout
por: Gáliková, Martina, et al.
Publicado: (2010)

Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
por: Leontieva, Olga V, et al.
Publicado: (2014)

Target of rapamycin signalling mediates the lifespan-extending effects of dietary restriction by essential amino acid alteration
por: Emran, Sahar, et al.
Publicado: (2014)

Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
por: Leontieva, Olga V., et al.
Publicado: (2011)

Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection
por: Larijani, Bagher, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_lqmen47nsfp0msoq3bldd2qjep